Skip to content
Menu
The Ivermectin Journal
  • About
  • Contact
The Ivermectin Journal
January 14, 2021

Getting coronavirus could protect against reinfection for at least 5 months: study

SOURCE: https://www.foxnews.com/health/covid-19-reinfection-uk-study

“The SIREN study from Public Health England’s (PHE) was performed among roughly 20,000 health care professionals and it found that only 44 participants of 6,614 who had COVID-19 antibodies upon recruitment experienced “possible” reinfection — representing an 83% less chance of infection compared to those without antibodies. The study was conducted between June 18 and Nov. 24. Antibody infection lasted for about five months, on average, from when participants were first infected, SIREN found.”

“We found that COVID-19 antibodies provide 83% protection against reinfection for at least 5 months.”

Subscribe to be notified of new posts!

Loading

Recent Posts

  • Doctors Sue FDA, Allege Crusade Against Ivermectin ‘Unlawfully Interfered’ With Their Ability to Treat Patients June 8, 2022
  • New Hampshire House Approves Legislation To Allow The Use of Ivermectin March 22, 2022
  • Ivermectin Beats Out 9 Other Meds for Treating Omicron, Study Confirms February 17, 2022
  • Critical Thinker? Watch Sen. Ron Johnson’s “COVID-19: A Second Opinion” Video! February 4, 2022
  • Omicron FLCCC Protocol Update January 25, 2022
  • NEW Treatment Protocol: I-RECOVER Management Protocol for Long Haul COVID-19 January 25, 2022
  • Large Brazilian, peer-reviewed research study proves Ivermectin works January 24, 2022
  • Check out the FLCCC’s Healthy Holiday Gift Guide December 17, 2021
©2025 The Ivermectin Journal | Powered by WordPress and Superb Themes!